The French Healthcare Minister has announced that the government will stop the funding of homeopathic remedies by 2021. It is estimated that the policy will save €127 million ($142.30 million). Homeopathy is an alternative medicine practice based on the philosophy that ‘like cures like.’ For example, if an ill person is displaying certain symptoms then […]
From September 2019 boys in England will be offered the HPV vaccine free on the NHS to reduce the spread of HPV related cancers. England will join Scotland and Australia in making the vaccine available to both genders to extend its successful immunisation programme. Human papillomavirus (HPV) causes the majority of cervical cancers cases in […]
Researchers have identified the genetic changes that cause corals to bleach when ocean temperatures increase. This insight gives researchers the possibility to genetically engineer corals to make them more resistant to bleaching. At normal temperatures, corals form a symbiotic relationship with microalgae, known as dinoflagellates. The algae provide their photosynthetic products to the coral so […]
A variant of the common cold virus has shown promising trial results as a treatment for bladder cancer. Bladder cancer is the tenth highest incident cancer in the UK and kills approximately 5,300 people a year. Current treatments for bladder cancer mostly have high recurrence rates or dangerous side-effects. 15 non-muscle invasive bladder cancer patients […]
Researchers have found a weakness in software used for genomics data storage, which could leave patients’ information vulnerable to cyber-attacks. The increasing speed and availability of genetic sequencing technologies has enabled personalised medicine to make significant progress over the last few years. Patient’s genetic profiles are considered when choosing chemotherapy treatment and cures are being […]
Patients with a certain genetic variant have been found to both be more pre-disposed to anxiety and depression and have lower susceptibility to the usual medication. Although anxiety and depression can be developed due to distressing events or stressful periods in a person’s life, there is increasing evidence that some people are more predisposed to […]
NASH is present in nine to 18 million people in America alone. Yet no single drug has yet been approved for its treatment. To discuss why therapies are proving so elusive, and where efforts will be made in the future, FLG has gathered some of the most influential names in the field to discuss the problem in our latest webinar: New Approaches to the Old Hunt for NASH Therapies, held at 4pm on 11 July 2019.
LGBT+ STEM Day – An Interview with Tom Welton, Dean of the Faculty of Natural Sciences at Imperial College London
In honour of LGBT+ STEM day we talked to Professor Tom Welton, Dean of the Faculty of Natural Sciences at Imperial College London and the President-Elect of the Royal Society of Chemistry. He shares his thoughts on diversity and inclusion in the workplace and how attitudes have changed towards LGBT+ people. FLG: What Issues Do […]
A new genetic test has been successfully trialled at a hospital in Oxford to help doctors identify patients most at risk of chemotherapy side-effects. Capecitabine and fluorouracil (5FU) are common chemotherapy drugs for cancers including breast, bowl and stomach. Both drugs act as anti-metabolites and resemble biological molecules found inside cells. When the drug molecules […]
A new CRISPR-based method has managed to eliminate HIV in mice, for the first time potentially curing the lifelong illness of HIV/AIDs. Clinical trials will start next year to identify if the same method could be used to cure humans. HIV is a virus which attacks the immune cells in the body, leaving it […]
Biobank 2019 – An Interview with Anthony Whetton, Professor of Cancer Cell Biology, University of Manchester
The UK Biobank’s 2019 scientific conference concluded this month. We talked to speaker Anthony Whetton, Professor of Cancer Cell Biology at the University of Manchester and Director of the Stoller Biomarker Discovery Centre, about large-scale multi-omic data within UK Biobank.
Fleeting genetic changes observed in stem cells as they differentiate could shed light on the origin of certain genetic diseases. Scientists studying stem cell differentiation usually only compare the differences in gene expression between the fully undifferentiated and differentiated cells. However, new research has revealed that the fleeting genetic changes during cell development could have […]
How DNA is packaged in human fat cells could be the reason why humans became fatter than their closest primate relatives, new research has shown. Whilst the healthy range for human body fat percentage lies between 14% and 31%, other primates have body fat percentages lower than 9%. The genetic reasons behind this difference could […]
Intermountain Healthcare and deCODE Genetics, a subsidiary of Amgen based in Iceland, have announced a major joint collaboration and study of 500,000 genomes centred around discovering new connections between genetics and human diseases. The study represents the largest US DNA-mapping attempt from a single population.
Inscripta has presented its scalable platform for benchtop digital CRISPR engineering, described as world first, at the 2019 Synthetic Biology: Engineering, Evolution & Design (SEED) conference. The technology, “CRISPR-enabled trackable genome engineering” or CREATE, is meant to remove certain limitations of CRISPR to allow for more wide-reaching research in the future.